Xtant Medical Inc. (XTNT) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Xtant Medical Inc. (XTNT)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.55

0.05 (10.00%)

At close: Jan 14, 2025, 3:57 PM

0.51

-7.23%

After-hours Jan 14, 2025, 08:00 PM EST

undefined% (undefined)

Bid	0.5
Market Cap	75.90M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.13
PE Ratio (ttm)	-4.2
Forward PE	n/a
Analyst	Strong Buy

Ask	0.8
Volume	48,304
Avg. Volume (20D)	137,311
Open	0.47
Previous Close	0.50
Day's Range	0.47 - 0.55
52-Week Range	0.33 - 1.30
Beta	undefined

About XTNT

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect ...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jul 1, 2010

Employees 207

Stock Exchange AMEX

Ticker Symbol XTNT

Website https://www.xtantmedical.com

Analyst Forecast

According to 1 analyst ratings, the average rating for XTNT stock is "Strong Buy." The 12-month stock price forecast is $3, which is an increase of 449.45% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Xtant Medical Inc. is scheduled to release its earnings on Mar 31, 2025, before market opens.
Analysts project revenue of $30.90M, reflecting a 9.93% YoY growth and earnings per share of -0.01, making a -66.67% decrease YoY.

Why Price Moved

9 months ago · Source

Xtant Medical Holdings shares are trading lower af... Unlock content with Pro Subscription

News

2 months ago · seekingalpha.com

Xtant Medical Holdings, Inc. (XTNT) Q3 2024 Earnings Conference Call Transcript

Xtant Medical Holdings, Inc. (NYSE:XTNT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Brett Maas - IR Sean Browne - President and CEO Scott Neils - CFO Conferenc...